Does the antisecretory peptide AF-16 reduce lung oedema in experimental ARDS?

AbstractBackground: Acute respiratory distress syndrome (ARDS) is an acute inflammatory condition with pulmonary capillary leakage and lung oedema formation. There is currently no pharmacologic tre...